Evidence map›Paper›PMID 37176980›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Novel Catalyst Composites of Ni- and Co-Based Nanoparticles Supported on Inorganic Oxides for Fatty Acid Hydrogenations.

Ekaterina Mamontova, Corine Trabbia, Isabelle Favier, Alejandro Serrano-Maldonado, Jean-Bernard Ledeuil, Lénaïc Madec, Montserrat Gómez, Daniel Pla

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bioinspired NiCoODiscover nano · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ekaterina MamontovaLaboratoire Hétérochimie Fondamentale et Appliquée, UMR CNRS 5069, Université Toulouse III-Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.ORCID 0000-0002-4959-3332
Corine TrabbiaLaboratoire Hétérochimie Fondamentale et Appliquée, UMR CNRS 5069, Université Toulouse III-Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.
Isabelle FavierLaboratoire Hétérochimie Fondamentale et Appliquée, UMR CNRS 5069, Université Toulouse III-Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.
Alejandro Serrano-MaldonadoLaboratoire Hétérochimie Fondamentale et Appliquée, UMR CNRS 5069, Université Toulouse III-Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.ORCID 0000-0003-3076-854X
Jean-Bernard LedeuilE2S UPPA, CNRS, IPREM, Université de Pau et des Pays de l'Adour, 64053 Pau, France.
Lénaïc MadecE2S UPPA, CNRS, IPREM, Université de Pau et des Pays de l'Adour, 64053 Pau, France.
Montserrat GómezLaboratoire Hétérochimie Fondamentale et Appliquée, UMR CNRS 5069, Université Toulouse III-Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.ORCID 0000-0003-1211-1333
Daniel PlaLaboratoire Hétérochimie Fondamentale et Appliquée, UMR CNRS 5069, Université Toulouse III-Paul Sabatier, 118 Route de Narbonne, CEDEX 9, 31062 Toulouse, France.ORCID 0000-0002-8703-8778

Funding

Centre National de la Recherche Scientifique nonPOCTEFA Interreg EFA308/19 (TRIPyr)Université Toulouse III - Paul Sabatier non
6 · The paper itself

Abstract

In the quest to develop nanometrically defined catalytic systems for applications in the catalytic valorization of agri-food wastes, small Ni-based nanoparticles supported on inorganic solid supports have been prepared by decomposition of organometallic precursors in refluxing ethanol under H

Indexed as

C=C bonds hydrogenationfatty acidsindustrial wastemagnesium aluminum oxide spinelnickel-based nanoparticlestitanium dioxide anatasevalorization

Identifiers

PMID37176980
PMCPMC10180328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.